Rankings
▼
Calendar
MDXG FY 2025 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena
MDXG
MiMedx Group, Inc.
$684M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$419M
+20.0% YoY
Gross Profit
$346M
82.6% margin
Operating Income
$64M
15.3% margin
Net Income
$49M
11.6% margin
EPS (Diluted)
$0.32
Cash Flow
Operating Cash Flow
$74M
Free Cash Flow
$73M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$343M
Total Liabilities
$86M
Stockholders' Equity
$257M
Cash & Equivalents
$166M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$419M
$349M
+20.0%
Gross Profit
$346M
$289M
+19.7%
Operating Income
$64M
$59M
+8.5%
Net Income
$49M
$42M
+14.5%
← Q4 2024
All Quarters
Q1 2025 →